(Q33500305)

27 July 2017

title

Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II study (English)

1 reference

27 July 2017

1 reference

1 reference

1 reference

3

G Fountzilas

1 reference

27 July 2017

P A Kosmidis

1

1 reference

27 July 2017

N Mylonakis

2

1 reference

27 July 2017

E Samantas

4

1 reference

27 July 2017

A Athanasiadis

5

1 reference

27 July 2017

E Andreopoulou

6

1 reference

27 July 2017

N Pavlidis

7

1 reference

27 July 2017

D Skarlos

8

1 reference

27 July 2017

publication date

1 July 1997

1 reference

27 July 2017

1 reference

27 July 2017

volume

8

1 reference

27 July 2017

issue

7

1 reference

27 July 2017

page(s)

697-699

1 reference

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008268911935

7 January 2021

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008268911935

7 January 2021

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008268911935

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008268911935

7 January 2021

A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non-operable non-small-cell lung cancer. A study of the Hellenic Co-operative Oncology Group for Lung Cancer Trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008268911935

7 January 2021

https://api.crossref.org/works/10.1023%2FA%3A1008268911935

1 reference

7 January 2021

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008268911935

7 January 2021

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008268911935

7 January 2021

Identifiers

DOI

10.1023/A:1008268911935

1 reference

27 July 2017

1 reference